Biofilms are complex microbial communities that tend to attach to either biotic or abiotic surface. Enclosed in a self-produced extracellular polymeric substance (EPS) matrix, the biofilms often cause persistent infections. The objective of this study was to investigate the antibiofilm activity of dimethyl sulfoxide (DMSO) and afatinib against Gram-negative pathogens. Test microorganisms used in this study were Escherichia coli ATCC 1299, Pseudomonas aeruginosa ATCC 10145, and Salmonella typhimurium ATCC 14028. Biofilms were developed in 96-well microplate at 37°C for 24 h. Following removal of non-adherent cells, analysis of biofilm viability, biofilm biomass, and extracellular polymeric substances (EPS) matrix were performed using resazurin assay, crystal violet assay, and attenuated total reflectance fourier transform infrared (ATR-FTIR) spectroscopy, respectively. Bradford protein assay was conducted to determine the total amount of EPS proteins. The results demonstrated that both 32% DMSO alone and its combination with 3.2 μg/mL afatinib were effective in killing biofilm cells and reducing biofilm biomass. IR spectral variations of EPS matrix of biofilms in the range between 1700 and 900 cm-1 were also observed. Reduction in EPS proteins verified the chemical modifications of EPS matrix. In conclusion, 32% DMSO alone and its combination with 3.2 μg/mL afatinib showed remarkable antibiofilm activities against Gram-negative pathogens. It was suggested that the biofilm inhibition was mediated by the chemical modification of EPS matrix.

Faculty of Applied Sciences Universiti Teknologi MARA Shah Alam 40450 Shah Alam Malaysia

Institute of Biological Sciences Faculty of Science University of Malaya 50603 Kuala Lumpur Malaysia

See more in PubMed

Arch Microbiol. 2006 Jan;184(5):271-8 PubMed

J Antibiot (Tokyo). 2012 Sep;65(9):453-9 PubMed

Science. 1999 May 21;284(5418):1318-22 PubMed

Antimicrob Agents Chemother. 2008 Aug;52(8):2870-81 PubMed

J Bacteriol. 2004 Dec;186(24):8254-66 PubMed

Genome Biol. 2003;4(6):219 PubMed

Appl Microbiol. 1968 Dec;16(12):1953-4 PubMed

Antimicrob Agents Chemother. 1994 Sep;38(9):2125-33 PubMed

Trends Microbiol. 2005 Jan;13(1):20-6 PubMed

Arzneimittelforschung. 1976;26(8):1581-3 PubMed

PLoS One. 2015 Sep 09;10(9):e0136190 PubMed

Nat Rev Microbiol. 2008 Mar;6(3):199-210 PubMed

J Microbiol Methods. 2001 Jul 30;46(1):9-17 PubMed

J Bacteriol. 2001 Dec;183(23):6746-51 PubMed

Microbiol Mol Biol Rev. 2009 Jun;73(2):310-47 PubMed

Sci Rep. 2014 Jan 17;4:3743 PubMed

Acta Anaesthesiol Scand. 1996 Mar;40(3):364-7 PubMed

Expert Opin Pharmacother. 2014 Jun;15(9):1277-88 PubMed

PLoS One. 2016 Mar 31;11(3):e0152538 PubMed

Int J Food Microbiol. 2013 Nov 1;167(3):293-302 PubMed

Appl Environ Microbiol. 2012 Mar;78(5):1454-65 PubMed

J Clin Aesthet Dermatol. 2012 Sep;5(9):24-6 PubMed

Science. 2012 Jan 6;335(6064):100-4 PubMed

Langmuir. 2011 Jun 7;27(11):6995-7001 PubMed

Br J Cancer. 2011 Nov 8;105(10 ):1554-62 PubMed

Microbiology. 2005 Dec;151(Pt 12):3817-32 PubMed

J Basic Microbiol. 2009 Aug;49(4):363-70 PubMed

Int J Food Microbiol. 2013 Mar 1;162(1):105-13 PubMed

Phys Chem Chem Phys. 2016 Apr 21;18(15):10270-80 PubMed